Benzinga  Jan 26  Comment 
Brean Capital reiterated its Sell rating on Rockwell Medical Inc (NASDAQ: RMTI) on Monday following the FDA approval of its Triferic iron replacement product. The firm maintained a $4 price target. Analysts Jonathan Aschoff and Yi Cheng...
FierceBiotech  Jan 26  Comment 
Rockwell Medical has overcome some hard questions and lingering doubts about its iron-replacement drug for dialysis patients, winning a long-sought FDA approval for Triferic and providing the biotech a green light to begin its marketing campaign.
MedPage Today  Jan 16  Comment 
(MedPage Today) -- Dialysis is a major lifestyle change, and not every patient can handle it.
NPR  Jan 15  Comment 
Dr. Leana Wen decided to leave frontline medical care to tend to the city of Baltimore's health needs. Geography and circumstance shouldn't determine someone's health destiny, she says.
MedPage Today  Jan 11  Comment 
(MedPage Today) -- Mortality rates in afflicted areas rose measurably.
Benzinga  Dec 22  Comment 
NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today that the U.S. Food and Drug Administration (FDA) has cleared its System Oneā„¢ to perform hemodialysis overnight while the patient is...
The Hindu Business Line  Dec 17  Comment 
Dialysis service provider NephroPlus on Wednesday announced plans for setting up 200 dialysis centres over the next five years across the country to mark its 15th foundation day. It also p...
Benzinga  Dec 17  Comment 
Cara Therapeutics, Inc. (Nasdaq: CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, today announced the successful completion of a...
MedPage Today  Dec 12  Comment 
(MedPage Today) -- Subgroup analyses of EVOLVE trial found the drug helps dialysis patients.
Wall Street Journal  Dec 10  Comment 
DSI Renal, a company that provides dialysis care to patients with chronic kidney failure and renal disease, is on the auction block and could fetch about $1 billion including debt.


Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki